Poised with unique advantages in drug transportation, RBC-based systems were further developed and in yet another study, an albumin bound NIR dye and DOX as a chemotherapeutic agent were co-encapsulated inside the RBCs and their surfaces were modified using target protein to achieve tumor targeting. This evidence concerns the gene ALB and neoplasm.